Compound ID | 2771
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Interferes with glucose utilization; competes as a substrate in adenosine anabolism |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Description: | Natural product from Streptomyces tubercidicus; also shows anti-tumour activity; shows host toxicity in preclinical studies |
| Institute where first reported: | Scientific Research Institute, Tokyo |
| Year first mentioned: | 1957 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6245 |
| Citations: |
|